Mosaic ImmunoEngineering Inc.
CPMV· OTC
CPMVMosaic ImmunoEngineering Inc.
Filed Aug 14, 2024 · 10-Q · 45 days after period end · 0001683168-24-005676
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$293.72K | $19.61K | -$929.63K | -$979.42K |
| EPS Diluted | -$0.04 | $0.00 | -$0.13 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Mosaic ImmunoEngineering Inc. · CIK 836564 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 14, 2024 · 45 d after period end
